Oclacitinib Oral Suspension (Anhydrous)
Oclacitinib is an FDA-approved preparation containing Oclacitinib, for veterinary use. Available by prescription.
How to Give Anhydrous Oral Suspension
Oral Suspension (Anhydrous) is a liquid medication that does not contain water in its base. This might be an oil-based or other special base to help stabilize the medicine. It will look like a regular liquid medication, but often needs a good shake because the drug can settle. Here's how to give it:
- Shake well each time to mix the medication (5-10 seconds).
- Measure the dose using the syringe/dropper provided or one recommended by your vet. Insert the top of the oral syringe into the bottle adapter. Turn the bottle upside down and pull the plunger until the medicine reaches the volume required
- Hold your pet steady: a towel or helper can assist with squirmy pets.
- Administer the dose slowly into the side of the mouth. Allow small pauses if needed for swallowing.
- Raise the head slightly to help the medication go down and clean any spills with a little water or tissue.
- Praise your pet and offer a treat or water (unless advised against feeding right after).
- Clean the syringe with water immediately after use. Store the bottle as directed, out of sunlight.
- Consistency is key: Shake each time, measure accurately, and contact your vet if any issues arise.
Oclacitinib, commercially available as Apoquel, is a Janus kinase (JAK) inhibitor utilized extensively in veterinary medicine for managing the body's response to environmental triggers. It is a prescription medication available for use in dogs, requiring a valid veterinarian-client-patient relationship. It is frequently considered in the context of allergic dermatitis for patients presented with significant itching.
The actions described here reflect the product's FDA-approved labeling; your veterinarian determines the appropriate use for your animal.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring.
At a pharmacological level, it is considered to influence the activity of JAK enzymes involved in signaling for itch and inflammation. Commonly observed effects include localized digestive changes such as vomiting or diarrhea and behavioral shifts like lethargy. Because it influences immune signaling, your veterinarian will monitor for observational signs of sensitivity or susceptibility to infection. Owners should monitor for any unusual lumps or persistent skin irritation and contact their veterinarian promptly with concerns.
Yes. Oclacitinib is a prescription medication and requires a valid authorization from a licensed veterinarian. Mixlab verifies all legal requirements before any medication is prepared or shipped.
Oclacitinib is a commercial tablet. If your dog requires a customized concentration or flavor, Mixlab can discuss specialized compounding options for the active ingredient based on a valid prescription.
Veterinarians discuss oclacitinib because it is considered to influence the specific signals in the body associated with the sensation of an "itch." This provides a method for addressing your pet's comfort during seasonal allergies.
No. Oclacitinib is a JAK inhibitor, which is a different class of medication than corticosteroids. Your veterinarian will determine if it is the right approach for your pet's inflammatory needs.
Oclacitinib is typically authorized for dogs above a specific age. Your veterinarian will determine if this management approach is appropriate based on your dog's age and health status.
